Global Gallbladder Cancer Treatment Market, By Indication Type (Stage I, Stage II, Stage III and Stage IV), Treatment Type (Surgery, Radiation Therapy, Chemotherapy and Immunotherapy), Diagnosis (Physical Examination, Liver Function Test, Blood Test, CT Scan, Ultrasound, Percutaneous Transhepatic Cholangiography (PTC), Endoscopic Retrograde Cholangiopancreatography (ERC), Magnetic Resonance Imaging (MRI), Endoscopic Ultrasound (EUS), Laparoscopy and Biopsy), Route of Administration (Oral and Injections), End Users (Hospitals, Gynaecology Clinics, Academic and Research Centres) – Industry Trends and Forecast to 2030.
Gallbladder Cancer Treatment Market Analysis and Size
Rising healthcare expenditure and adoption of advanced and innovative diagnostic and treatment methods may also drive the global gallbladder cancer treatment market growth. The increase in respectability rate and overall survival which shows positive results can act as an opportunity for the global gallbladder cancer treatment market growth. Complete surgical tumour resection is the only treatment for the gallbladder cancer but the resection is one of the challenging tasks due to presence of important structures such as porta hepatica and there are some chances that the cancer can invade to the hepatic region.
Data Bridge Market Research analyses that the global gallbladder cancer treatment market which was USD 79.5 million in 2022, is expected to reach USD 121.4 million by 2030, and is expected to undergo a CAGR of 6.50% during the forecast period 2023-2030. This indicates that the market value. “Liver Function Test” dominates the diagnosis segment of the global gallbladder cancer treatment market owing to an increase in the prevalence of gallbladder cancer worldwide. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Gallbladder Cancer Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indication Type (Stage I, Stage II, Stage III and Stage IV), Treatment Type (Surgery, Radiation Therapy, Chemotherapy and Immunotherapy), Diagnosis (Physical Examination, Liver Function Test, Blood Test, CT Scan, Ultrasound, Percutaneous Transhepatic Cholangiography (PTC), Endoscopic Retrograde Cholangiopancreatography (ERC), Magnetic Resonance Imaging (MRI), Endoscopic Ultrasound (EUS), Laparoscopy and Biopsy), Route of Administration (Oral and Injections), End Users (Hospitals, Gynaecology Clinics, Academic and Research Centres)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Medtronic (U.S.), B. Braun Melsungen AG (Germany), Johnson & Johnson Private Limited (U.S.), Smith+Nephew (U.K.), Symmetry Surgical Inc. (U.S.), CONMED Corporation (U.S.), Olympus Corporation – (Japan), Boston Scientific Corporation (U.S.), Cipla Inc. (India), Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Sanofi (France), OncoTherapy Science, Inc. (Japan), Intuitive Surgical (U.S.), Samarth Pharma Pvt. Ltd. (India), GLS pharma ltd., Sun Pharmaceutical Industries Ltd. (India)
|
|
Market Opportunities
|
|
Market Definition
Gallbladder is an organ which is situated under the lungs and is small and pear-shaped organ. The overgrowth of cancer or malignant cells in the tissues of the gallbladder leads to gallbladder cancer. The type of cancer is rare and mainly affects the female population. Different symptoms of gallbladder cancer are pain (above stomach), jaundice, lumps in the abdomen and fever. The gallbladder cancer is very difficult to detect in the early stage as there is absence of signs and if signs are there, it represents the other illnesses. For the treatment of cancer, different methods such as chemotherapy, immunotherapy, surgery and many other methods are done according to the patient’s adaptability and stage of the cancer. Drugs which are used for the treatment are gemzar, platinol, 5-fluorouracil, xeloda, and eloxatin. Immunotherapy drugs used for the treatment of cancer are nivolumab (opdivo) and pembrolizumab (keytruda). According to American Cancer Society, only 1 out of 5 gallbladder cancers are detected at early stage.
Global Gallbladder Cancer Treatment Market Dynamics
Drivers
- Increasing Incidence of Gallbladder Cancer
A significant driver is the rising incidence of gallbladder cancer, particularly in regions where it is more prevalent, such as South Asia and South America. This drives the demand for diagnostic and treatment options.
- Advancements in Medical Technology
Advances in medical technology, including improved diagnostic methods (such as imaging and biomarker detection) and minimally invasive surgical techniques, have enhanced the ability to diagnose and treat gallbladder cancer effectively.
- Growing Awareness and Early Detection
Increased awareness of gallbladder cancer risk factors, such as obesity and gallstones, has led to more individuals seeking regular check-ups and early detection. Early diagnosis often leads to better treatment outcomes
- Growing Investment in Research and Development
Investment in research and development by pharmaceutical and biotechnology companies has led to the development of new drugs and therapies for gallbladder cancer treatment. These innovations can expand treatment options and improve patient outcomes.
Opportunities
- Emerging Markets
Growing healthcare infrastructure and increasing medical tourism in emerging markets present significant growth opportunities for gallbladder cancer treatment manufacturers.
- Advances in Genomics and Precision Medicine
Advances in genomics and precision medicine offer an opportunity to tailor treatments based on the genetic profile of individual patients. Developing targeted therapies for specific genetic mutations associated with gallbladder cancer can improve treatment efficacy and reduce side effects.
Restraints/ Challenges
- High Cost of Treatment
Cancer treatment, including surgery, chemotherapy, and radiation therapy, can be expensive. High treatment costs can be a barrier to access for some patients, particularly in regions with limited healthcare resources.
- Limited Treatment Options
Compared to some other types of cancer, there are relatively fewer treatment options available for gallbladder cancer. Surgery remains the primary treatment, and there is a need for more effective adjuvant therapies, such as chemotherapy and radiation therapy.
- Competitive Market
Early diagnosis is crucial for improving gallbladder cancer outcomes, but reliable early detection methods are limited. Most cases are diagnosed at advanced stages when treatment options are more limited. Developing effective screening and early detection methods remains a significant challenge.
- Limited Early Detection Methods
Ensuring that healthcare professionals are well-trained in electrosurgery techniques is crucial to prevent complications. Addressing the shortage of skilled operators can be challenging.
This global gallbladder cancer treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gallbladder cancer treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In December 2022, India-based startup PredOmix launched a one-of-its-kind innovative cancer detection blood test, OncoVeryx-F, capable of detecting early-stage cancers in women with a 98% accuracy
- In June 2022, Roche launched the new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care
Global Gallbladder cancer treatment Market Scope
Global gallbladder cancer treatment market is segmented on the basis of indication type, treatment type, diagnosis, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Indication Type
- Stage I
- Stage II
- Stage III
- Stage IV
Treatment Type
- Surgery
- Cholecystectomy
- Radical Gallbladder Resection
- Palliative Surgery
- Radiation therapy
- Chemotherapy
- Monotherapy
- Combination Therapy
- Immunotherapy
Diagnosis
- Physical Examination
- Liver function Test
- Blood Test
- CT Scan
- Ultrasound
- Percutaneous Transhepatic Cholangiography (PTC)
- Endoscopic Retrograde Cholangiopancreatography (ERC)
- Magnetic Resonance Imaging (MRI)
- Endoscopic Ultrasound (EUS)
- Laparoscopy
- Biopsy
Route of Administration
- Oral
- Injections
End Users
- Hospitals
- Gynaecology Clinics
- Academic and Research Centers
Global Gallbladder cancer treatment Market Analysis/Insights
The global gallbladder cancer treatment market is analysed and market size insights and trends are provided by country, indication type, treatment type, diagnosis, route of administration and end users as referenced above.
The countries covered in the global gallbladder cancer treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America dominates the global gallbladder cancer treatment market due to high adoption rate of advanced technology and the presence of skilled professionals within the region.
Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period of 2023 to 2030 owing to the growing foreign direct investments, increase in disposable incomes and rising awareness about advanced and minimally invasive surgical techniques in patients.
The country section of the global gallbladder cancer treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The global gallbladder cancer treatment market is analysed and market size insights and trends.
Competitive Landscape and Global Gallbladder cancer treatment Market Share Analysis
The global gallbladder cancer treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global gallbladder cancer treatment market.
Some of the major players operating in the global gallbladder cancer treatment market are:
- Medtronic (U.S.)
- B. Braun Melsungen (Germany)
- Johnson & Johnson Private Limited (U.S.)
- Smith+Nephew (U.K.)
- Symmetry Surgical Inc. (U.S.)
- CONMED Corporation (U.S.)
- Erbe Elektromedizin GmbH (Germany)
- Olympus Corporation (Japan)
- Boston Scientific Corporation (U.S.)
- Cipla Inc. (India)
- Bristol-Myers Squibb Company (U.S.)
- Eli Lilly and Company (U.S.)
- Pfizer Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Sanofi (France)
- OncoTherapy Science, Inc. (Japan)
- Intuitive Surgical (U.S.)
- Samarth Pharma Pvt. Ltd. (India)
- Sun Pharmaceutical Industries Ltd. (India)
SKU-